IQ-AI Limited (IQAI) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Mar 2024 07:00 AM
RNS
Grant of Options
01 Mar 2024 08:22 AM
RNS
Holding(s) in Company
01 Mar 2024 08:20 AM
RNS
Holding(s) in Company
26 Feb 2024 07:00 AM
RNS
Result of Broker Option and Total Voting Rights
22 Feb 2024 07:00 AM
RNS
Placing and Broker Option
09 Feb 2024 12:49 PM
RNS
FDA Application Update
02 Feb 2024 08:39 AM
RNS
IB awarded a $100,000 grant
02 Feb 2024 08:39 AM
RNS
IB awarded a $100,000 grant
22 Jan 2024 10:05 AM
RNS
Holding(s) in Company
15 Jan 2024 07:01 AM
RNS
Director Dealings and Conversion of CLNs
15 Jan 2024 07:00 AM
RNS
Holding(s) in Company
10 Jan 2024 07:00 AM
RNS
IB Launching an Expanded Access Program for GaM
19 Dec 2023 02:29 PM
RNS
Imaging Biometrics granted FDA “Fast-Track”
05 Dec 2023 10:58 AM
RNS
IQ-AI Announces Positive Interim Phase 1 Results
20 Nov 2023 01:42 PM
RNS
Holding(s) in Company
09 Nov 2023 11:38 AM
RNS
Director Dealing and Conversion of CLNs
08 Nov 2023 10:59 AM
RNS
Application for Pediatric Rare Disease Designation
06 Nov 2023 01:02 PM
RNS
Holding(s) in Company
18 Oct 2023 02:29 PM
RNS
Update Regarding Imaging Biometrics LLC
13 Oct 2023 08:55 AM
RNS
IB Letter to Shareholders
09 Oct 2023 07:00 AM
RNS
Orphan Drug Status to GaM and Total Voting Rights
03 Oct 2023 11:30 AM
RNS
Holding(s) in Company
19 Sep 2023 02:32 PM
RNS
IQ-AI shares cease trading on the OTCQB
08 Sep 2023 07:00 AM
RNS
Reduced Gadolinium Approach Validated'
18 Aug 2023 12:06 PM
RNS
Update on Collaboration Agreement with Mayo Clinic
18 Aug 2023 11:20 AM
RNS
IB & GE HealthCare Enter into Commercial Agreement
17 Aug 2023 07:00 AM
RNS
Half-year Report
19 Jul 2023 07:00 AM
RNS
Imaging Biometrics Installs IB Nimble™ For MCW
13 Jul 2023 07:00 AM
RNS
Orphan Drug Designation for GaM in Pediatric GBM
27 Jun 2023 07:00 AM
RNS
Studies Show GaM Inhibits Pediatric Tumor Growth
23 May 2023 11:02 AM
RNS
Result of AGM
23 May 2023 07:00 AM
RNS
AGM Statement
03 May 2023 04:14 PM
RNS
Notice of AGM
26 Apr 2023 07:00 AM
RNS
Final Results
28 Feb 2023 03:52 PM
RNS
Orphan Drug Designation Status
13 Jan 2023 02:05 PM
RNS
Second Price Monitoring Extn
13 Jan 2023 02:00 PM
RNS
Price Monitoring Extension
13 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
13 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
10 Jan 2023 07:00 AM
RNS
Letter to Shareholders
02 Dec 2022 11:11 AM
RNS
Holding in Company
25 Oct 2022 11:00 AM
RNS
Price Monitoring Extension
30 Sep 2022 07:00 AM
RNS
Letter to Shareholders
26 Sep 2022 07:00 AM
RNS
Issue of Warrants to Employees
16 Aug 2022 04:40 PM
RNS
Second Price Monitoring Extn
16 Aug 2022 04:35 PM
RNS
Price Monitoring Extension
16 Aug 2022 09:28 AM
RNS
Half-year Report
03 Aug 2022 01:01 PM
RNS
TR1 - Notification of Major Holdings
11 Jul 2022 07:00 AM
RNS
Imaging Biometrics Announces Channel Partnership
31 May 2022 11:05 AM
RNS
Second Price Monitoring Extn
UK 100

Latest directors dealings